Express Pharma

APRIL 20, 2023

This way the business program of PHARMAP 2023 is created to discuss and examine new trends for reshaping the pharma industry. COVID-19 has sped up the digital transformation and forced pharmaceutical companies to rethink many aspects of their business. Sustainability topic, you see that a lot of changes are going on with the packages.

Packaging 52

Packaging Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

OCTOBER 3, 2024

While it officially applies to the manufacture of sterile medicinal products in the European Union, the revised EU Good Manufacturing Practice (GMP) Annex 1 effectively reset the benchmark for quality standards across the globe on 25 August 2023. Register your details to read more The post How ready are you?

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

European Pharmaceutical Review

NOVEMBER 24, 2023

Recent European manufacturing investments Earlier this month, Novo Nordisk announced that it was planning another manufacturing facility expansion, this time at its site in Kalundborg, Denmark. In September, the Novo Nordisk Foundation announced a multi-million financial commitment to another Denmark-based manufacturing facility.

Pharmaceutical Manufacturing 98

Pharmaceutical Manufacturing Packaging 98

GMPSOP

DECEMBER 10, 2023

Particularly the printed packaging materials where product information is presented. Printed packaging materials typically include product names, active ingredients, concentration, batch numbers, expiry dates, registration numbers, barcodes, etc. Commonly used packaging materials are cartons, inserts, leaflets, printed foil, etc.

Packaging 40

Packaging Health and Personal Care Stores Labelling Documentation 40

Express Pharma

NOVEMBER 15, 2024

This indicates that, despite some progress, a significant portion of the sector still needs to elevate its ESG practices, as per an October 2023 report from Deloitte, titled, ‘Embedding environmental sustainability into pharma’s DNA’. Embedding sustainability into the core business strategy is essential for long-term success.

Packaging 102

Packaging Generic Medicine Pharmaceutical Manufacturing Vaccines 102

Quality Matters

NOVEMBER 5, 2024

Insights from USP’s Medicine Supply Map demonstrate that geographic concentration of pharmaceutical manufacturing anywhere in the world – including within the United States – increases the risk for drug shortages. Promoting geographic diversity of the manufacturing base of U.S.

Pharmaceutical Manufacturing 78

Pharmaceutical Manufacturing Packaging Documentation 78

Quality Matters

AUGUST 3, 2023

They comprise interconnected webs of local and global ingredient suppliers, manufacturers, packagers, distributors, providers, and regulators. active ingredients, excipients, other raw materials) Packaging materials (e.g., josh.levin@usp.org Thu, 08/03/2023 - 15:43 Supply Chain

Packaging 52

Packaging Compounding Pharmacies Pharmaceutical Manufacturing Documentation 52

Pharmaceutical Technology

NOVEMBER 21, 2022

However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Drug Pricing 69

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 69

Quality Matters

APRIL 18, 2024

Importantly, these efforts can provide USP Convention Member organizations and Expert Volunteers with even more transparency on the impact we are collectively making to improve global public health, bolster environmental sustainability of the pharmaceutical supply chain, and build trust in science-based institutions like USP.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Packaging Generic Medicine 59

Pharmaceutical Technology

NOVEMBER 21, 2022

However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

GMPSOP

MAY 26, 2023

Six steps process to implement change control management Pharmaceuticals quality assurance & validation procedures GMPSOP Six steps process to implement change control management Last modified: June 3, 2023 Table of Contents “It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change”.

Documentation 52

Documentation Packaging Communication Customer Service 52

GMPSOP

MAY 26, 2023

Six steps process to implement change control management Pharmaceuticals quality assurance & validation procedures GMPSOP Six steps process to implement change control management Last modified: May 28, 2023 Table of Contents “It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change”.

Documentation 52

Documentation Packaging Communication Customer Service 52

GMPSOP

JUNE 28, 2024

In the five years between 2019 and 2023, the FDA issued the following warning letters, closely related to ineffective deviation investigation. Adulterated Pharmaceuticals: 396 warnings iii. Packaging/labeling/Misbranding: 41 warnings vi. CGMP Deviation: 39 warnings ii. Adulterated API: 39 warnings iv.

Documentation 59

Documentation Packaging Labelling Pharmaceutical Manufacturing 59

GMPSOP

OCTOBER 28, 2023

Packaging material specifications In the pharmaceutical industry, the requirements for pre-printed packaging materials must be well-defined and documented to ensure that you get the items you specified or ordered and that there are no mix-ups. A standard name and a unique item code define packaging materials.

Documentation 52

Documentation Method Validation Packaging Data Entry 52

PharmaShots

FEBRUARY 27, 2023

Some of their thoughts are: Mr. Mekala Rao (Chairman – Technology Global PHT Expo & Summit – 2023 and President – Atachi Systems, USA) – “motivation to attend Global PHT is to understand the cultural gap in the production of innovative medicine, healthcare systems between eastern and western world.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

GMPSOP

JULY 14, 2023

In this article, we will discuss important aspects of equipment cleaning that are required during pharmaceutical manufacturing. In other areas, such as in secondary packaging or in material storage areas, the product isn’t exposed to the environment, so there is a lower risk of contamination.

Documentation 52

Documentation Labelling Pharmaceutical Manufacturing Packaging 52

European Pharmaceutical Review

AUGUST 10, 2023

Amidst numerous warning letters distributed by the US Food and Drug Administration (FDA) to pharmaceutical manufacturers in recent months, in July this year, the US regulatory body published its analysis on drug product quality in 2022. Edge Biologicals Inc., An FDA warning letter delivered to Edge Biologicals Inc.

Pharmaceutical Manufacturing 98

Pharmaceutical Manufacturing Packaging 98

Pharmaceutical Technology

MARCH 22, 2023

To keep the EU’s medicine supply intact, Gupta suggests governments should adopt new pricing policies and provide further aid to mitigate the impact of rising operational costs; they should also minimise the exodus of generics manufacturers.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

Pharmaceutical Technology

FEBRUARY 9, 2023

Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceutical manufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.

Packaging 52

Packaging Pharmaceutical Manufacturing Communication Pharmaceutical Companies 52